DIAN DIAGNOSTICS(SZ:300244) Sou Hu Cai Jing·2026-01-13 05:30Group 1 - The A-share market experienced significant fluctuations on January 13, with the medical device ETF (562600) showing strong performance, rising by 1.58% [1] - The medical technology sector is gaining momentum, driven by AI applications in healthcare, with companies like Di'an Diagnostics hitting the daily limit and Jiukang Bio rising by 12.86% [1] - The medical device ETF (562600) has seen a net inflow of 140 million yuan over the past five trading days, indicating investor confidence in the medical technology sector [1] Group 2 - The medical device ETF (562600) is a key tool for investing in cutting-edge medical technology, tracking the CSI All-Share Medical Device Index, with a significant 23.8% weight in brain-computer interface stocks [2] - The ETF has a high industry exposure of 89.2%, including leading companies like Mindray Medical, United Imaging, and Di'an Diagnostics, effectively capturing the benefits of niche market growth [2] - Investors can participate in the medical device ETF through low-threshold options like the Huaxia CSI All-Share Medical Device ETF Initiated Link A (021250) and C shares (021251) for long-term growth opportunities [2]